138 related articles for article (PubMed ID: 32515032)
1. High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines.
Akahane K; Yasuda T; Tsuzuki S; Hayakawa F; Kiyokawa N; Somazu S; Watanabe A; Kagami K; Abe M; Harama D; Goi K; Kawazu M; Kojima S; Imamura T; Goto H; Iwamoto S; Minegishi M; Abe M; Hojo H; Inaba T; Mano H; Sugita K; Inukai T
Hematol Oncol; 2020 Oct; 38(4):614-617. PubMed ID: 32515032
[No Abstract] [Full Text] [Related]
2. Clinical and molecular characteristics of
Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
[TBL] [Abstract][Full Text] [Related]
3. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
[TBL] [Abstract][Full Text] [Related]
4. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel
Van Outersterp I; Hormann FM; Hoogkamer AQ; Boeree A; Van den Broek SA; Den Boer ML; Boer JM
Haematologica; 2023 Oct; 108(10):2859-2864. PubMed ID: 37051743
[No Abstract] [Full Text] [Related]
6. Transcriptional activities of DUX4 fusions in B-cell acute lymphoblastic leukemia.
Tanaka Y; Kawazu M; Yasuda T; Tamura M; Hayakawa F; Kojima S; Ueno T; Kiyoi H; Naoe T; Mano H
Haematologica; 2018 Nov; 103(11):e522-e526. PubMed ID: 29773604
[No Abstract] [Full Text] [Related]
7. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract][Full Text] [Related]
8. Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions.
Sun K; Chen WM; Wang X; Zhao XS; Li LD; Hao Y; Wang J; Xu N; Jiang Q; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Qin YZ
Hematol Oncol; 2023 Aug; 41(3):594-597. PubMed ID: 36516881
[No Abstract] [Full Text] [Related]
9. The pathogenic role of MEF2D-SS18 fusion gene in B-cell acute lymphoblastic leukemia.
Zhang M; Mao D; Zhang W
Biochem Biophys Res Commun; 2018 Feb; 496(4):1331-1336. PubMed ID: 29408457
[TBL] [Abstract][Full Text] [Related]
10. High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse.
McClure BJ; Heatley SL; Rehn J; Breen J; Sutton R; Hughes TP; Suppiah R; Revesz T; Osborn M; White D; Yeung DT; White DL
Br J Haematol; 2020 Oct; 191(2):301-304. PubMed ID: 32731299
[No Abstract] [Full Text] [Related]
11.
Sadras T; Müschen M
Blood Cancer Discov; 2020 Jul; 1(1):18-20. PubMed ID: 34661138
[TBL] [Abstract][Full Text] [Related]
12. Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells.
Tange N; Hayakawa F; Yasuda T; Odaira K; Yamamoto H; Hirano D; Sakai T; Terakura S; Tsuzuki S; Kiyoi H
Biomed Pharmacother; 2020 Aug; 128():110330. PubMed ID: 32504922
[TBL] [Abstract][Full Text] [Related]
13. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
[TBL] [Abstract][Full Text] [Related]
14. Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion.
Zhang M; Zhang H; Li Z; Bai L; Wang Q; Li J; Jiang M; Xue Q; Cheng N; Zhang W; Mao D; Chen Z; Huang J; Meng G; Chen Z; Chen SJ
Blood; 2022 Sep; 140(12):1390-1407. PubMed ID: 35544603
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13).
Yuki Y; Imoto I; Imaizumi M; Hibi S; Kaneko Y; Amagasa T; Inazawa J
Cancer Sci; 2004 Jun; 95(6):503-7. PubMed ID: 15182431
[TBL] [Abstract][Full Text] [Related]
16. B-lymphoblastic lymphoma with
Kubota-Tanaka M; Osumi T; Miura S; Tsujimoto H; Imamura T; Nishimura A; Oki K; Nakamura K; Miyamoto S; Inoue K; Inoue M; Kamiya T; Yanagimachi M; Okano T; Mitsuiki N; Isoda T; Imai K; Kanegane H; Morio T; Kounami S; Endo M; Kato M; Takagi M
Haematologica; 2019 Jan; 104(1):e35-e37. PubMed ID: 30262566
[No Abstract] [Full Text] [Related]
17. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
[No Abstract] [Full Text] [Related]
18. Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.
Hirano D; Hayakawa F; Yasuda T; Tange N; Yamamoto H; Kojima Y; Morishita T; Imoto N; Tsuzuki S; Mano H; Naoe T; Kiyoi H
Oncogene; 2019 Mar; 38(13):2263-2274. PubMed ID: 30478446
[TBL] [Abstract][Full Text] [Related]
19. Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia.
Tsuzuki S; Yasuda T; Kojima S; Kawazu M; Akahane K; Inukai T; Imaizumi M; Morishita T; Miyamura K; Ueno T; Karnan S; Ota A; Hyodo T; Konishi H; Sanada M; Nagai H; Horibe K; Tomita A; Suzuki K; Muramatsu H; Takahashi Y; Miyazaki Y; Matsumura I; Kiyoi H; Hosokawa Y; Mano H; Hayakawa F
Blood Cancer Discov; 2020 Jul; 1(1):82-95. PubMed ID: 34661142
[TBL] [Abstract][Full Text] [Related]
20. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
